Amanda M Termuhlen

Summary

Affiliation: University of Southern California
Country: USA

Publications

  1. doi request reprint Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology Group
    Amanda M Termuhlen
    Department of Pediatrics, Keck School of Medicine, University of Southern California 701 E 28th St, Suite 202, Long Beach, CA 90806, USA
    Pediatr Blood Cancer 59:1229-33. 2012
  2. doi request reprint Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study
    Amanda M Termuhlen
    Department of Pediatrics, University of Southern California, Miller Children s Hospital, Long Beach, California 90806, USA
    Pediatr Blood Cancer 57:1210-6. 2011
  3. doi request reprint Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the Children's Oncology Group
    Amanda M Termuhlen
    Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Br J Haematol 162:792-801. 2013
  4. pmc Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents
    Thomas G Gross
    Department of Pediatrics, Nationwide Children s Hospital, Ohio State University, Columbus, Ohio 43205, USA
    Biol Blood Marrow Transplant 16:223-30. 2010
  5. doi request reprint Mobilization of PML-RARA negative blood stem cells and salvage with autologous peripheral blood stem cell transplantation in children with relapsed acute promyelocytic leukemia
    Amanda M Termuhlen
    Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA
    Pediatr Blood Cancer 51:521-4. 2008
  6. ncbi request reprint Autologous hematopoietic stem cell transplant with melphalan and thiotepa is safe and feasible in pediatric patients with low normalized glomerular filtration rate
    Amanda M Termuhlen
    Department of Pediatrics, The Ohio State University College of Medicine and Public Health, Columbus, OH, USA
    Pediatr Transplant 10:830-4. 2006
  7. ncbi request reprint Pediatric non-Hodgkin's lymphoma
    Thomas G Gross
    Department of Pediatrics, The Ohio State University School of Medicine, Division of Hematology Oncology BMT, Children s Hospital, 700 Children s Drive, Columbus, OH 43205, USA
    Curr Oncol Rep 9:459-65. 2007
  8. ncbi request reprint Pediatric non-Hodgkin lymphoma
    Thomas G Gross
    Department of Pediatrics, The Ohio State University School of Medicine, Division of Hematology Oncology BMT, Children s Hospital, 700 Children s Drive, Columbus, OH, 43205, USA
    Curr Hematol Malig Rep 3:167-73. 2008
  9. doi request reprint Rare pediatric non-hodgkin lymphoma
    Bhuvana A Setty
    Department of Pediatrics, Nationwide Children s Hospital, Division of Hematology Oncology BMT, 700 Children s Drive, Columbus, OH 43205, USA
    Curr Hematol Malig Rep 5:163-8. 2010

Detail Information

Publications9

  1. doi request reprint Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology Group
    Amanda M Termuhlen
    Department of Pediatrics, Keck School of Medicine, University of Southern California 701 E 28th St, Suite 202, Long Beach, CA 90806, USA
    Pediatr Blood Cancer 59:1229-33. 2012
    ..We report the 5-year event-free survival (EFS) and overall survival (OS) for children and adolescents with localized LL treated on a uniform regimen based on Children's Cancer Group (CCG) leukemia therapy (COG A5971)...
  2. doi request reprint Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study
    Amanda M Termuhlen
    Department of Pediatrics, University of Southern California, Miller Children s Hospital, Long Beach, California 90806, USA
    Pediatr Blood Cancer 57:1210-6. 2011
    ..Treatment cures over 90% of children with Wilms tumor (WT) who subsequently risk late morbidity and mortality. This study describes the 25-year outcomes of 5-year WT survivors in the Childhood Cancer Survivor Study (CCSS)...
  3. doi request reprint Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the Children's Oncology Group
    Amanda M Termuhlen
    Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Br J Haematol 162:792-801. 2013
    ..CNS positive patients (n = 12) did poorly [5-year EFS of 63% (95% CI 29-85%)]. For CNS-negative patients, there was no difference in outcome based on CNS prophylaxis (IT-MTX versus HD-MTX) or with intensification. ..
  4. pmc Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents
    Thomas G Gross
    Department of Pediatrics, Nationwide Children s Hospital, Ohio State University, Columbus, Ohio 43205, USA
    Biol Blood Marrow Transplant 16:223-30. 2010
    ..These data were unable to demonstrate a difference in outcome by donor type for the other histological subtypes...
  5. doi request reprint Mobilization of PML-RARA negative blood stem cells and salvage with autologous peripheral blood stem cell transplantation in children with relapsed acute promyelocytic leukemia
    Amanda M Termuhlen
    Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA
    Pediatr Blood Cancer 51:521-4. 2008
    ..The effect of arsenic trioxide on autologous peripheral blood stem cell collection is unknown...
  6. ncbi request reprint Autologous hematopoietic stem cell transplant with melphalan and thiotepa is safe and feasible in pediatric patients with low normalized glomerular filtration rate
    Amanda M Termuhlen
    Department of Pediatrics, The Ohio State University College of Medicine and Public Health, Columbus, OH, USA
    Pediatr Transplant 10:830-4. 2006
    ..These cases demonstrate that it is feasible and safe to perform HSCT in pediatric patients with low nGFR using melphalan- and thiotepa-based preparative therapy...
  7. ncbi request reprint Pediatric non-Hodgkin's lymphoma
    Thomas G Gross
    Department of Pediatrics, The Ohio State University School of Medicine, Division of Hematology Oncology BMT, Children s Hospital, 700 Children s Drive, Columbus, OH 43205, USA
    Curr Oncol Rep 9:459-65. 2007
    ..This review focuses on current treatments for pediatric NHL and some of the differences between NHL observed in pediatric and adult patients...
  8. ncbi request reprint Pediatric non-Hodgkin lymphoma
    Thomas G Gross
    Department of Pediatrics, The Ohio State University School of Medicine, Division of Hematology Oncology BMT, Children s Hospital, 700 Children s Drive, Columbus, OH, 43205, USA
    Curr Hematol Malig Rep 3:167-73. 2008
    ..This review focuses on current treatments for pediatric NHL and some of the differences between NHL observed in pediatric and adult patients...
  9. doi request reprint Rare pediatric non-hodgkin lymphoma
    Bhuvana A Setty
    Department of Pediatrics, Nationwide Children s Hospital, Division of Hematology Oncology BMT, 700 Children s Drive, Columbus, OH 43205, USA
    Curr Hematol Malig Rep 5:163-8. 2010
    ..It is important to improve understanding and treatment of these rare pediatric NHLs through international collaborative efforts...